미세잔존질환(MRD) 검사 시장 : 제품별, 기술별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Minimal Residual Disease Testing Market size was valued at USD 1,456 Million in 2024, expanding at a CAGR of 12.5% from 2024 to 2032.

Minimal Residual Disease (MRD) testing is a diagnostic tool used to detect the presence of residual cancerous cells that remain in a patient after treatment. These cells are often at extremely low levels and are undetectable through traditional imaging or biopsy methods. MRD testing is particularly important in hematologic cancers, such as leukemia and lymphoma, where it helps to identify patients at risk of relapse. By detecting minimal disease levels, MRD testing can guide treatment decisions, monitor disease progression, and help assess the effectiveness of ongoing therapies. It is essential for personalized patient care and improving outcomes.

Minimal Residual Disease Testing Market- Market Dynamics

Increasing Demand for Personalized Medicine

The growing demand for personalized medicine is a significant driver in various healthcare sectors, including cancer treatment and diagnostics. Personalized medicine focuses on tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors, enhancing the effectiveness and reducing adverse effects. This trend has accelerated the adoption of technologies like Minimal Residual Disease (MRD) testing. By identifying patients at high risk for relapse, MRD testing facilitates more targeted therapies, improving outcomes. As personalized treatment plans become increasingly popular, the market for advanced diagnostic tools, such as MRD testing, is expected to expand, offering healthcare professionals better options to manage and treat diseases effectively. This shift towards individualized care supports growth in related diagnostic markets.

Minimal Residual Disease Testing Market- Key Insights

According to our research analyst, the global Minimal Residual Disease Testing Market is expected to develop at a CAGR of approximately 12.5% between 2024-2032.

Segmented by Product in 2024, the Assay Kits & Reagents category dominated the market.

Based on Technology, the Polymerase Chain Reaction generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Minimal Residual Disease Testing Market- Segmentation Analysis:

The global Minimal Residual Disease Testing Market is divided into five categories: Product, Technology, Application, End User and Region.

The Minimal Residual Disease (MRD) testing market is primarily divided into two segments: Assay Kits & Reagents and Instruments. Assay kits and reagents are essential for performing MRD tests, providing the necessary components for sample analysis, and ensuring accurate detection of minimal residual disease at low levels. These kits are in high demand due to their cost-effectiveness, ease of use, and ability to deliver precise results. On the other hand, instruments such as flow cytometers and PCR machines are crucial for executing MRD tests and analyzing the samples. While both segments are critical to the testing process, Assay Kits & Reagents dominate the market. Their affordability and adaptability to various testing environments make them a preferred choice in clinical diagnostics and research. The growth in personalized medicine further supports the increasing demand for these products.

The MRD testing market is segmented by technology into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Flow Cytometry, and Other Technologies. Polymerase Chain Reaction (PCR) is a widely used technology due to its ability to amplify specific DNA sequences, enabling the detection of low levels of residual disease with high sensitivity. Next-Generation Sequencing (NGS) is a more advanced technology that offers deep sequencing capabilities, providing detailed insights into genetic mutations and aiding in detecting minimal disease. Flow Cytometry uses fluorescently labeled antibodies to identify and quantify specific cell types, playing a pivotal role in identifying abnormal or residual cells in blood samples. While all technologies offer significant advantages, Polymerase Chain Reaction (PCR) dominates the market due to its established reliability, widespread adoption, and cost-effectiveness. It remains the most preferred method for MRD testing, especially in clinical settings, due to its precision and scalability in detecting minimal disease levels.

Minimal Residual Disease Testing Market- Geographical Insights

Geographically, the Minimal Residual Disease Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

In North America, the United States is the dominant player in the Minimal Residual Disease (MRD) testing market, driven by advanced healthcare infrastructure, significant research and development activities, and a high adoption rate of cutting-edge technologies. The U.S. leads in personalized medicine and molecular diagnostics, with major healthcare institutions and biotech companies investing in MRD testing technologies. Canada follows closely, benefiting from strong healthcare policies and a well-developed healthcare system. The increasing demand for precision medicine and advanced diagnostic tools in both countries supports robust market growth.

In Europe, Germany stands out as a key market for MRD testing, owing to its strong healthcare system, significant investment in biotechnology, and well-established research institutions. Germany's emphasis on precision medicine and early detection of diseases fuels the adoption of MRD testing. The United Kingdom is another dominant player, with a well-funded healthcare sector and high demand for advanced diagnostics. The UK's active participation in research and clinical trials, along with increasing awareness of minimal residual disease, makes it a critical market for MRD testing within Europe.

Minimal Residual Disease Testing Market- Competitive Landscape:

The competitive dynamics of the Minimal Residual Disease (MRD) Testing market are shaped by both established healthcare and diagnostic players, as well as emerging innovators. Major players like F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, and Guardant Health Inc. dominate with cutting-edge MRD testing solutions, offering high accuracy and sensitivity. These firms invest heavily in R&D to enhance their diagnostic technologies and maintain regulatory compliance. New entrants, such as Adaptive Biotechnologies and Archerdx, focus on innovative methods like next-generation sequencing (NGS) and liquid biopsy, which improve detection and monitoring. This competition fosters continual advancements in MRD testing, enhancing patient outcomes.

Recent Developments:

In April 2025, Guardant Health introduced a significant upgrade to its liquid biopsy platform, enhancing its ability to detect minimal residual disease (MRD) with greater sensitivity. This advancement allows for earlier detection of cancer recurrence, enabling more timely and targeted interventions. The platform's increased sensitivity is particularly beneficial in monitoring patients post-treatment, improving overall patient outcomes.

In July 2024, Roche completed the acquisition of LumiraDx's point-of-care technology, aiming to expand access to diagnostic testing in primary care settings. This acquisition enhances Roche's capabilities in providing decentralized testing solutions, facilitating earlier detection and monitoring of diseases, including MRD, in diverse healthcare environments. The integration of LumiraDx's technology aligns with Roche's strategy to broaden the reach of its diagnostic services globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• F. Hoffmann-La Roche AG
• Laboratory Corporation of America Holdings
• Guardant Health Inc.
• Sysmex Corporation
• Neogenomics Laboratories
• Molecularmd
• Adaptive Biotechnologies
• Archerdx
• Bio-Rad Laboratories Inc.
• Natera, Inc.
• Opko Health x
• Others

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

• Assay Kits & Reagents
• Instruments

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

• Polymerase Chain Reaction
• Next-Generation Sequencing
• Flow Cytometry
• Other Technologies

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

• Hematological Malignancies
• Leukemia
• Myeloid Leukemia
• Lymphocytic Leukemia
• Other Leukemias
• Lymphoma
• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Solid Tumors
• Multiple Myeloma
• Other Applications

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

• Hospitals and Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Minimal Residual Disease Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Minimal Residual Disease Testing Market Snippet by Product
  • 2.1.2. Minimal Residual Disease Testing Market Snippet by Technology
  • 2.1.3. Minimal Residual Disease Testing Market Snippet by Application
  • 2.1.4. Minimal Residual Disease Testing Market Snippet by End User
  • 2.1.5. Minimal Residual Disease Testing Market Snippet by Country
  • 2.1.6. Minimal Residual Disease Testing Market Snippet by Region
• 2.2. Competitive Insights

3. Minimal Residual Disease Testing Key Market Trends

• 3.1. Minimal Residual Disease Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Minimal Residual Disease Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Minimal Residual Disease Testing Market Opportunities
• 3.4. Minimal Residual Disease Testing Market Future Trends

4. Minimal Residual Disease Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Minimal Residual Disease Testing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Minimal Residual Disease Testing Market Landscape

• 6.1. Minimal Residual Disease Testing Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Minimal Residual Disease Testing Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
  • 7.1.2. Assay Kits & Reagents
  • 7.1.3. Instruments

8. Minimal Residual Disease Testing Market - By Technology

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
  • 8.1.2. Polymerase Chain Reaction
  • 8.1.3. Next-Generation Sequencing
  • 8.1.4. Flow Cytometry
  • 8.1.5. Other Technologies

9. Minimal Residual Disease Testing Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2. Hematological Malignancies
    • 9.1.2.1. Leukemia
    • 9.1.2.1.1. Myeloid Leukemia
    • 9.1.2.1.2. Lymphocytic Leukemia
    • 9.1.2.1.3. Other Leukemias
    • 9.1.2.2. Lymphoma
    • 9.1.2.2.1. Non-Hodgkin Lymphoma
    • 9.1.2.2.2. Hodgkin Lymphoma
  • 9.1.3. Solid Tumors
  • 9.1.4. Multiple Myeloma
  • 9.1.5. Other Applications

10. Minimal Residual Disease Testing Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 10.1.2. Hospitals and Specialty Clinics
  • 10.1.3. Diagnostic Laboratories
  • 10.1.4. Academic & Research Institutes
  • 10.1.5. Other End Users

11. Minimal Residual Disease Testing Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Minimal Residual Disease Testing Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Minimal Residual Disease Testing Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Minimal Residual Disease Testing Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Minimal Residual Disease Testing Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Minimal Residual Disease Testing Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Minimal Residual Disease Testing Industry

• 12.1. Competitive Dashboard
  • 12.1.1. Competitive Benchmarking
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. F. Hoffmann-La Roche AG
  • 12.2.2. Laboratory Corporation of America Holdings
  • 12.2.3. Guardant Health Inc.
  • 12.2.4. Sysmex Corporation
  • 12.2.5. Neogenomics Laboratories
  • 12.2.6. Molecularmd
  • 12.2.7. Adaptive Biotechnologies
  • 12.2.8. Archerdx
  • 12.2.9. Bio-Rad Laboratories Inc.
  • 12.2.10. Natera, Inc.
  • 12.2.11. Opko Health
  • 12.2.12. Others

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us